Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Total Liabilities (2010 - 2026)

Geron's (GERN) quarterly Total Liabilities came in at $300.4 million in Q2 2026, up 1.6% year-over-year from $295.7 million in Q2 2025, and down 1.51% quarter-over-quarter from $305.0 million in Q1 2026.

Analysis

Geron (GERN) Total Liabilities (2010 - 2026) Analysis & Trends

Geron has disclosed Total Liabilities across 17 years of filings, most recently posting $300.4 million for Q2 2026.

  • In Q2 2026, Total Liabilities rose 1.6% year-over-year to $300.4 million; the TTM figure through Jun 2026 stood at $300.4 million (up 1.6% YoY), while the FY2025 annual figure was $344.7 million, up 9.96% from the prior year.
  • Total Liabilities came in at $300.4 million for Q2 2026 at Geron, down from $305.0 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $344.7 million in Q4 2025 to a low of $96.1 million in Q2 2022.
  • Average Total Liabilities over 5 years is $195.6 million, with a median of $144.4 million recorded in 2023.
  • Year-over-year, Total Liabilities slipped 2.09% in 2023 and soared 114.51% in 2024.
  • Over 5 years, Total Liabilities stood at $110.6 million in 2022, then soared by 32.15% to $146.1 million in 2023, then soared by 114.51% to $313.5 million in 2024, then increased by 9.96% to $344.7 million in 2025, then fell by 12.85% to $300.4 million in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $300.4 million in Q2 2026, $305.0 million in Q1 2026, and $344.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 Geron 914.60 Mn 613.75 Mn - 300.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300.40 Mn
Mar 31, 2026 305.01 Mn
Dec 31, 2025 344.67 Mn
Sep 30, 2025 318.68 Mn
Jun 30, 2025 295.67 Mn
Mar 31, 2025 294.21 Mn
Dec 31, 2024 313.46 Mn
Sep 30, 2024 152.67 Mn
Jun 30, 2024 142.70 Mn
Mar 31, 2024 137.21 Mn
Dec 31, 2023 146.13 Mn
Sep 30, 2023 122.40 Mn
Jun 30, 2023 116.87 Mn
Mar 31, 2023 98.82 Mn
Dec 31, 2022 110.58 Mn
Sep 30, 2022 124.43 Mn
Jun 30, 2022 96.11 Mn
Mar 31, 2022 100.93 Mn
Dec 31, 2021 99.62 Mn
Sep 30, 2021 77.54 Mn